Financial News [16 April 2018]

“한국제약바이오협회, ‘공공의료기관 처방의약품 목록에 개발신약 의무 등재 필요'” – “Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA): ‘There is a need to list newly developed pharmaceutical drugs on the list of prescription drugs for public medical institutions.'”

Click here to read the article